凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

交易中 11-09 15:34:35

122.500

-5.900

-4.60%

最高131.600	最低122.200	成交量80.34万
今开131.600	昨收128.400	日振幅7.32%
总市值443.45亿	流通市值34.10亿	总股本3.62亿
成交额1.01亿	换手率2.89%	流通股本2,783万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":122.5,"timestamp":1794209673819,"preClose":128.4,"halted":0,"volume":803400,"delay":0,"changeRate":-0.045950155763239915,"floatShares":27834500,"shares":362000000,"eps":3.71312884205244,"marketStatus":"交易中","change":-5.9,"latestTime":"11-09 15:34:35","open":131.6,"high":131.6,"low":122.2,"amount":100862100,"amplitude":0.073209,"askPrice":122.8,"askSize":3100,"bidPrice":122.5,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":3.932704011102747,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794211800000},"marketStatusCode":2,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":128.4,"dividendRate":0.012528,"openAndCloseTimeList":[[1794187800000,1794196800000],[1794200400000,1794211200000]],"volumeRatio":0.751274,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":150.24,"timestamp":1794207600000,"preClose":155.03,"halted":0,"volume":9147700,"delay":0,"premium":"-30.61"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2682876428","title":"【券商聚焦】招银国际：中国创新药出海BD是核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2682876428","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682876428?lang=zh_cn&edition=full","pubTime":"2026-11-09 13:15","pubTimestamp":1794201346,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，2026年三季度，海外CXO和生命科学上游公司业绩延续逐季改善趋势，收入与调整后EPS中位数增速分别达+8.3%和+13.4%。生命科学上游改善最明显，CDMO受高基数影响增速放缓，临床前与临床CRO订单增长强劲，行业普遍上调全年指引。临床CRO订单维持增长，但可靠性受关注。生物药CDMO需求仍旺盛，但高基数致增速放缓。创新药融资三季度增速放缓，但2026全年预计实质性反弹，中国创新药出海BD是核心动力。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995526","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","LU0572944931.SGD","06821","LU0043850808.USD","LU2045819591.USD","IE00BFMHRM44.USD","LU0320764599.SGD","LU0455707207.USD","BK1141","LU0540923850.HKD","LU0128526141.USD","BK1610","LU0516422440.USD","01873","LU0181495838.USD","BK1191","HK0000320223.HKD","LU0051755006.USD","LU1688375341.USD","02359","KURE","HK0000306701.USD","06127","LU0417516902.SGD","LU0039217434.USD","LU0359202008.SGD","01548","LU0634319403.HKD","LU0856984785.SGD","KCE","LU0456846285.SGD","LU0348825331.USD","LU2039709279.SGD","LU0819121731.USD","BK1576","LU2399975544.HKD","01521","HK0000306685.HKD","LU0072913022.USD","LU0327786744.USD","LU0359201612.USD","03759","LU1242518931.SGD","LU0979878070.USD","02269","LU1046422090.SGD","LU0501845795.SGD","03347","LU0823426308.USD","LU0149721374.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681864216","title":"凯莱英（002821）披露回购股份用于注销并减少注册资本暨通知债权人的公告，11月06日股价下跌3.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681864216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681864216?lang=zh_cn&edition=full","pubTime":"2026-11-06 21:43","pubTimestamp":1793972625,"startTime":"0","endTime":"0","summary":"截至2026年11月6日收盘，凯莱英报收于155.03元，较前一交易日下跌3.98%，最新总市值为561.13亿元。预计回购股份数量不低于2,032,520股且不高于2,845,528股，占公司总股本比例约为0.56%至0.79%。回购实施期限为董事会审议通过之日起12个月内。公司债权人可自公告发布之日起45日内申报债权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110600032804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002821","06821","LU1328615791.USD","BK0239","BK0132","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681183700","title":"大行评级｜小摩：中国CDMO进入新发展阶段，首予康龙化成及凯莱英H股“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2681183700","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681183700?lang=zh_cn&edition=full","pubTime":"2026-11-06 15:23","pubTimestamp":1793949835,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0216","BK1191","BK1141","BK0132","LU1328615791.USD","BK1576","06821","300759","002821","03759","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165726962","title":"异动解读｜凯莱英盘中上涨5.19%，A股回购注销方案持续提振情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1165726962","media":"行情直击","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165726962?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:55","pubTimestamp":1793930108,"startTime":"0","endTime":"0","summary":"11月6日，凯莱英盘中上涨5.19%，报135.8港元，成交额6041.8万港元。消息面上，公司日前披露A股回购方案，拟以集中竞价方式回购股份，金额不低于5亿元且不超过7亿元，回购价格上限为246元／股。公告显示，回购股份将用于员工持股计划或股权激励，并可用于注销减少注册资本；按上限测算，预计回购约203万股至285万股，占总股本约0.56%至0.79%。公司前三季度实现营收53.95亿元、归母净利润8.52亿元，第三季度单季净利润同比增长81.49%，为回购方案提供了经营支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯莱英回购注销提振信心，股价强势上涨","news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161269992","title":"凯莱英（06821）拟最高7亿元回购A股并注销　债权人45日内可申报债权","url":"https://stock-news.laohu8.com/highlight/detail?id=1161269992","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161269992?lang=zh_cn&edition=full","pubTime":"2026-11-05 21:01","pubTimestamp":1793883685,"startTime":"0","endTime":"0","summary":"2026年11月6日，凯莱英医药集团（天津）股份有限公司发布公告称，公司已于2026年11月4日召开第五届董事会第十七次会议，通过《关于回购公司股份方案的议案》，决定以集中竞价方式回购部分A股股份，用于后续实施股权激励或员工持股计划，并在实施后予以注销以减少注册资本。根据2025年度股东会已授权的股份回购权限，本次事项无需再次提交股东大会审议。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165089997","title":"凯莱英（06821）公布最高7亿元A股回购方案并披露前十大股东持股","url":"https://stock-news.laohu8.com/highlight/detail?id=1165089997","media":"公告速递","labels":["shareholding","buyback","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165089997?lang=zh_cn&edition=full","pubTime":"2026-11-05 20:51","pubTimestamp":1793883076,"startTime":"0","endTime":"0","summary":"凯莱英医药集团（天津）股份有限公司11月6日公告称，2026年11月4日公司召开第五届董事会第十七次会议，审议通过《关于回购公司股份方案的议案》，拟以集中竞价方式回购部分A股股份，资金总额不低于5亿元且不超过7亿元，资金来源为自有资金及自筹资金。回购股份将用于后续实施员工持股计划或股权激励，或用于注销以减少注册资本。截至2026年11月4日，公司A股前十名股东合计持股169,869,098股，持股比例50.33%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681042909","title":"11月5日凯莱英涨8.47%，中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2681042909","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681042909?lang=zh_cn&edition=full","pubTime":"2026-11-05 17:04","pubTimestamp":1793869473,"startTime":"0","endTime":"0","summary":"证券之星消息，11月5日凯莱英涨8.47%，收盘报161.45元，换手率4.3%，成交量13.62万手，成交额21.87亿元。根据2026基金Q3季报公募基金重仓股数据，重仓该股的公募基金共243家，其中持有数量最多的公募基金为中欧基金的中欧医疗健康混合A。中欧医疗健康混合A目前规模为132.77亿元，最新净值1.9091，较上一交易日上涨6.41%，近一年上涨0.16%。中欧医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500029772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","06821","002821","LU1328615791.USD","BK1191","BK0132","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681701264","title":"港股异动 | 凯莱英(06821.HK)涨超4% 拟回购不低于5亿元A股 公司新兴业务持续放量","url":"https://stock-news.laohu8.com/highlight/detail?id=2681701264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681701264?lang=zh_cn&edition=full","pubTime":"2026-11-05 13:58","pubTimestamp":1793858297,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["82822","83130","02846","03188","02823","82843","BK1610","07233","03130","83188","02843","06821","82823","82846","02822","BK1147","02827","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172533853","title":"异动解读｜凯莱英盘中上涨11.21%，启动5亿至7亿元A股回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1172533853","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172533853?lang=zh_cn&edition=full","pubTime":"2026-11-05 10:32","pubTimestamp":1793845950,"startTime":"0","endTime":"0","summary":"11月5日，凯莱英盘中上涨11.21%，报134.9港元，成交额1.05亿港元。消息面上，公司公告拟回购A股股份，金额不低于5亿元且不超过7亿元，回购价格上限为246元／股，拟用于后续员工持股计划、股权激励或注销减少注册资本。按公告测算，预计回购约203万股至285万股，占总股本约0.56%至0.79%。结合公司前三季度实现营收53.95亿元、归母净利润8.52亿元，以及第三季度单季净利润同比增长81.49%，回购计划进一步强化了市场对公司经营与股东回报的关注。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"凯莱英放量上涨，启动5亿至7亿元回购","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680052194","title":"凯莱英(06821)拟回购公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2680052194","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680052194?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:52","pubTimestamp":1793800321,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，公司拟回购A股股份，将用于后续实施员工持股计划或者股权激励及注销减少注册资本。本次回购股份资金不低于5亿元且不超过7亿元。本次回购股份价格不超过246元/股，本次具体回购资金总额以实际使用的资金总额为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","02827","BK1610","07233","LU1328615791.USD","BK1191","82843","06821","82823","BK0132","159982","03188","83188","02823","03130","02846","BK1147","82846","02822","02843","399300","83130","82822","002821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131062871","title":"凯莱英（06821）启动A股回购计划 资金上限7亿元、最高回购0.79%股本","url":"https://stock-news.laohu8.com/highlight/detail?id=1131062871","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131062871?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:45","pubTimestamp":1793799935,"startTime":"0","endTime":"0","summary":"2026年11月5日，凯莱英医药集团（天津）股份有限公司公告称，董事会已于11月4日审议通过A股股份回购方案，并依据此前股东大会授予的一般性授权，无需再提交股东大会审议。根据公告，公司拟通过深圳证券交易所集中竞价交易方式回购人民币普通股（A股），回购资金总额不低于5亿元且不超过7亿元，回购价格上限为246元/股。用于激励的股份须在回购完成后36个月内授予；未授出的部分将按规定予以注销并减少注册资本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159837674","title":"凯莱英（06821）拟回购5亿至7亿元A股 用于员工激励与股份注销","url":"https://stock-news.laohu8.com/highlight/detail?id=1159837674","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159837674?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:40","pubTimestamp":1793799632,"startTime":"0","endTime":"0","summary":"北京时间2026年11月5日，凯莱英医药集团（天津）股份有限公司发布公告称，公司第五届董事会第十七次会议已于2026年11月4日以通讯方式召开，并审议通过《关于回购公司股份方案的议案》。根据公告，凯莱英拟使用自有资金及自筹资金回购A股股份，预计回购金额区间为5亿元至7亿元人民币。其中，员工持股计划或股权激励部分须在回购完成后36个月内授予，逾期未授予的股份将依法注销并减少注册资本。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680068732","title":"凯莱英：第五届董事会第十七次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2680068732","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680068732?lang=zh_cn&edition=full","pubTime":"2026-11-04 21:22","pubTimestamp":1793798520,"startTime":"0","endTime":"0","summary":"证券日报网讯 11月4日，凯莱英发布公告称，公司于2026年11月4日召开第五届董事会第十七次会议，审议通过《关于回购公司股份方案的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-11-04/doc-inixqsyn9321108.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-11-04/doc-inixqsyn9321108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002821","BK0239","LU1328615791.USD","BK0132","BK1191","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680059914","title":"凯莱英拟回购5亿元至7亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2680059914","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680059914?lang=zh_cn&edition=full","pubTime":"2026-11-04 20:37","pubTimestamp":1793795820,"startTime":"0","endTime":"0","summary":"11月4日，凯莱英（002821/06821）发布公告，计划回购股份，资金总额不低于5亿元且不超过7亿元，回购价格上限为246元/股，预计回购股份数量在203万股至285万股，占公司总股本的0.56%至0.79%。2026年前三季度，凯莱英实现收入53.95亿元，归母净利润8.52亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611043922172444.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611043922172444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1328615791.USD","06821","BK0239","002821","BK1191","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680903947","title":"凯莱英涨10.00%，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2680903947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680903947?lang=zh_cn&edition=full","pubTime":"2026-11-04 17:37","pubTimestamp":1793785061,"startTime":"0","endTime":"0","summary":"今日凯莱英涨10.00%，收盘报148.84元。2026年8月27日，开源证券研究员余汝意发布了对凯莱英的研报《公司信息更新报告：收入稳健增长，在手订单高增夯实全年确定性》，该研报对凯莱英给出“买入”评级。研报中预计2026-2028年公司归母净利润为15.07/18.59/23.12亿元，EPS为4.18/5.15/6.41元，当前股价对应PE为41.2/33.4/26.9倍，维持“买入”评级。凯莱英个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400032952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","002821","06821"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680086498","title":"异动快报：凯莱英（002821）11月4日13点32分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2680086498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680086498?lang=zh_cn&edition=full","pubTime":"2026-11-04 13:36","pubTimestamp":1793770574,"startTime":"0","endTime":"0","summary":"证券之星11月4日盘中消息，13点32分凯莱英（002821）触及涨停板。其所属行业医疗服务目前上涨。领涨股为凯莱英。该股为化学原料药，创新药，减肥药概念热股，当日化学原料药概念上涨1.73%，创新药概念上涨1.64%，减肥药概念上涨1.45%。11月3日的资金流向数据方面，主力资金净流入4502.7万元，占总成交额5.07%，游资资金净流入5369.56万元，占总成交额6.05%，散户资金净流出9872.26万元，占总成交额11.12%。近5日资金流向一览见下表：凯莱英主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400021223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","06821","BK1191","LU1328615791.USD","002821","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088259","title":"CRO概念股早盘涨幅居前 凯莱英及药明生物均涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088259","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088259?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:32","pubTimestamp":1793763120,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端CRO概念股早盘涨幅居前，截至发稿，凯莱英（06821）上涨5.77%，报113.60港元；药明生物（02269）上涨5.20%，报45.30港元；药明康德（02359）上涨5.28%，报185.30港元；康龙化成（03759）上涨3.39%，报26.88港元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-11-04/doc-inixpvva1659648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0359202008.SGD","LU0543330566.HKD","LU0516422952.EUR","KURE","BK1610","LU0417516902.SGD","LU0708995583.HKD","LU0307460666.USD","LU0634319403.HKD","LU0326950275.SGD","LU0979878070.USD","LU0516423174.USD","02269","LU1880383366.USD","LU0181495838.USD","LU0819121731.USD","LU0359201612.USD","LU0823426308.USD","BK0239","LU0456846285.SGD","LU1328277881.USD","LU0029874061.USD","LU0516422366.SGD","LU0052750758.USD","LU0348735423.USD","LU1720050803.USD","LU0229945570.USD","LU2399975544.HKD","BK1141","SG9999002463.SGD","06821","LU0823426480.USD","LU0128522744.USD","LU3063872942.SGD","LU0348827113.USD","LU0320764599.SGD","IE00B0JY6N72.USD","002821","LU2476274308.USD","BK1191","LU2476274720.SGD","LU1961090484.USD","LU0051755006.USD","LU0456827905.SGD","LU0561508036.HKD","BK1576","IE00BFMHRM44.USD","LU2039709279.SGD","LU0327786744.USD","LU0516423091.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088151","title":"凯莱英(06821)早盘涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088151","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088151?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:11","pubTimestamp":1793761860,"startTime":"0","endTime":"0","summary":"11月4日，凯莱英早盘涨超7%，截至发稿，涨4.75%，报112.50港元，成交额5084万港元。2026年前三季度，公司实现营业总收入53.95亿元，同比增长16.5%；归母净利润8.52亿元，同比增长6.5%。其中第三季度实现营业总收入17.88亿元，同比增长24.0%；归母净利润3.32亿元，同比增长81.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611043921469886.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611043921469886.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK0239","002821","BK0132","06821","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680519700","title":"CXO板块逆市走强 百济神州（06160）涨5.14%、凯莱英（06821）涨4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680519700","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680519700?lang=zh_cn&edition=full","pubTime":"2026-11-04 10:34","pubTimestamp":1793759693,"startTime":"0","endTime":"0","summary":"金吾财讯 | CXO板块逆市走强，百济神州 涨5.14%，凯莱英涨4.19%，药明康德涨3.92%，药明生物涨3.58%，科伦博泰生物涨2.89%，药明合联涨2.44%，和铂医药-B涨1.76%，康龙化成涨1.46%，和黄医药涨1.17%。湘财证券表示，CXO龙头药明康德三季报超预期、指引上修，印证CXO由周期修复转向CRDMO结构性重估。维持药品行业“买入”评级，建议关注创新化学制剂及创新药产业链上游CXO公司。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995187","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WX","LU0051755006.USD","02268","LU2476274720.SGD","CXO","LU1720050803.USD","LU2476274308.USD","ONC","02359","LU0516422440.USD","LU0828237510.HKD","02269","06160","688235","LU0128522744.USD","LU0501845795.SGD","03759","LU0456827905.SGD","LU0348766576.USD","BK1574","LU0823426480.USD","LU0455707207.USD","BK0132","SG9999002562.SGD","LU0043850808.USD","LU0359202008.SGD","LU0502904849.HKD","LU2045819591.USD","02142","KURE","LU0072913022.USD","LU0229945570.USD","LU0823426308.USD","LU0588546209.SGD","SG9999002463.SGD","06990","LU0327786744.USD","LU0320764243.SGD","LU3063872942.SGD","00013","BK1141","LU1831875114.USD","LU0463099449.HKD","002821","LU0516423091.SGD","LU0326950275.SGD","06821","LU1242518857.USD","LU0128526141.USD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680427797","title":"凯莱英（002821）披露证券变动月报表，11月03日股价下跌1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680427797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680427797?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:58","pubTimestamp":1793703492,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，凯莱英报收于135.31元，较前一交易日下跌1.58%，最新总市值为489.75亿元。该股当日开盘136.8元，最高138.9元，最低131.55元，成交额达8.88亿元，换手率为2.07%。凯莱英于2026年11月3日披露《证券变动月报表》公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300036587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","06821","002821","LU1328615791.USD","BK1191","BK0132","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.2358},{"period":"1month","weight":-0.2242},{"period":"3month","weight":0.0808},{"period":"6month","weight":0.2889},{"period":"1year","weight":0.5637},{"period":"ytd","weight":0.8283}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.058449},{"month":2,"riseRate":0.4,"avgChangeRate":0.006895},{"month":3,"riseRate":0.4,"avgChangeRate":0.004398},{"month":4,"riseRate":0.6,"avgChangeRate":-0.036171},{"month":5,"riseRate":0.4,"avgChangeRate":0.006805},{"month":6,"riseRate":0.6,"avgChangeRate":0.053806},{"month":7,"riseRate":0.6,"avgChangeRate":0.056483},{"month":8,"riseRate":0.4,"avgChangeRate":-0.032767},{"month":9,"riseRate":0.8,"avgChangeRate":0.210834},{"month":10,"riseRate":0,"avgChangeRate":-0.178493},{"month":11,"riseRate":0.6,"avgChangeRate":0.055642},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010173}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}